2024 SPEAKERS

 

APRIL 1-4, 2024
WALTER E CONVENTION CENTER WASHINGTON DC

 

 

Peter Abbink, Managing Director, Batavia Biosciences

Peter Abbink | Managing Director | Batavia Biosciences » speaking at Vaccine Congress USA

Zaid Abdulghany, Director of Manufacturing and Technical Operations, IDT Biologika

Brian Abramson, Board of Directors, National Vaccine Law Association

Dr Thomas Acciani, Director, US Vaccine Policy, GSK

Analia Acebal, Vaccine Manufacturing Lead Consultant, CEPI

Analia Acebal | Vaccine Manufacturing Lead Consultant | CEPI » speaking at Vaccine Congress USA

Sarita Acharya, Principal Scientist, USP

Emily Acker, Director, Infectious Disease Policy, Biotechnology Innovation Organization

Ryan Ades, Director of IPPE and Experiential Curriculum, Purdue University

Rania Al Shami, Chief Business and Strategy Officer, PDC CRO

Hansilla Alaigh, Head of Alliances & Business Operations, Seqirus

Hansilla Alaigh | Head of Alliances & Business Operations | Seqirus » speaking at Vaccine Congress USA

Syed Khalid Ali, CSO, Panacea Biotech

Yewande Alimi, One Health unit lead, Africa CDC

Yewande Alimi | One Health unit lead | Africa CDC » speaking at Vaccine Congress USA

Sally Allain, Head, JLABS - Washington, DC, Johnson & Johnson Innovation, Johnson & Johnson

Sally Allain | Head, JLABS - Washington, DC, Johnson & Johnson Innovation | Johnson & Johnson » speaking at Vaccine Congress USA

Andrew Allen, President & CEO, Gritstone bio

Richard Alm, CSO, CARB-X

Mashal Almutairi, Chief Executive Officer, Scientific Affairs and Vaccines Development and Manufacturing, Vaccine Industrial Company

Mashal Almutairi | Chief Executive Officer, Scientific Affairs and Vaccines Development and Manufacturing | Vaccine Industrial Company » speaking at Vaccine Congress USA

Pedro L. Alonso, Head of Global Health Office, Senior Vice President Science and Medicine, BioNTech

Sarah Alsuleiman, Associate Research Scientist, Athari BioSciences, Inc.

Galit Alter, VP of Immunology Research, Moderna

Galit Alter | VP of Immunology Research | Moderna » speaking at Vaccine Congress USA

Kishore Alugupalli, CEO, TurboVax Inc, TurboVax Inc.

Annaliesa Anderson, SVP and Head, Vaccine R&D, Pfizer

Annaliesa Anderson | SVP and Head, Vaccine R&D | Pfizer » speaking at Vaccine Congress USA

Tavis Anderson, Research Biologist, USDA

Germán Áñez, Executive Director, Vaccines Clinical Research, Merck and Co.

Akwasi Apori, Chief Executive Officer, Correlia Biosystems

Phyllis Arthur, Senior Vice President, Infectious Diseases & Emerging Science Policy, Biotechnology Innovation Organization (BIO)

Luigi Aurisicchio, Chief Executive Officer, Neomatrix

Kabeer Aziz, Co-Founder & Principal, Adjuvant Capital

Kabeer Aziz | Co-Founder & Principal | Adjuvant Capital » speaking at Vaccine Congress USA

Ali Azizi, Project Lead, CEPI

Irnela Bajrovic, Chief Scientific Officer, Jurata Thin Film, Inc.

Aida Bakri, Director of Secretariat, Global One Health Community

Varun Bansal, Scientist, Microbiologics

Basam Barkho, Technical Marketing Manager, Aldevron

Dan Barouch, Professor Of Medicine, Harvard Medical School

Dan Barouch | Professor Of Medicine | Harvard Medical School » speaking at Vaccine Congress USA

Mario Barro, Director of Innovation, Vaccines, RA Capital

Mario Barro | Director of Innovation, Vaccines | RA Capital » speaking at Vaccine Congress USA

Colin Basler, One Health Office Deputy Director and CDC One Health Liaison to WOAH, CDC

Rosemary Bastian, Director, Translational Science, BioNTech SE

Rosemary Bastian | Director, Translational Science | BioNTech SE » speaking at Vaccine Congress USA

Miranda Baxa, Research Director, Immunisation Readiness Index; Consultant, Health Policy & Insights, Economist Impact

Abebe Genetu Bayih, Ag. PAVM Coordinator, Africa CDC

Abebe Genetu Bayih | Ag. PAVM Coordinator | Africa CDC » speaking at Vaccine Congress USA

Thomas Beadnell, Associate Scientific Advisor, Eurofins Viracor BioPharma

Thomas Beadnell | Associate Scientific Advisor | Eurofins Viracor BioPharma » speaking at Vaccine Congress USA

Ghiorghis Belai, Vice President, Global Strategy, FHI Clinical

Ghiorghis Belai | Vice President, Global Strategy | FHI Clinical » speaking at Vaccine Congress USA

Kaïdre Bendjama, CSO, NEC OncoImmunity AS

Kaïdre Bendjama | CSO | NEC OncoImmunity AS » speaking at Vaccine Congress USA

Christine Stabell Benn, Professor, University of Southern Denmark

Hamilton Bennett, Sr. Director Vaccine Access and Partnerships, Moderna

Jay Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Gilles Besin, Chief Scientific Officer, Orbital Therapeutics

Jeffrey Bethony, Professor & Vice Chair for Translational Research, Department of Microbiology, Immunology & Tropical Medicine, The George Washington University

Jeffrey Bethony | Professor & Vice Chair for Translational Research, Department of Microbiology, Immunology & Tropical Medicine | The George Washington University » speaking at Vaccine Congress USA

Alexandra Bhatti, Director of U.S. Vaccine Public Policy, Merck

Kara Bickham, Vice President of Clinical Research and Development, Pfizer

Karin Bok, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH

Karin Bok | Director of Pandemic Preparedness and Emergency Response | Vaccine Research Center, NIAID, NIH » speaking at Vaccine Congress USA

Luciana Borio, Venture Partner, A.R.C.H. Venture Partners

Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine

Maria Elena Bottazzi | Co-Director of Texas Children's Hospital Center for Vaccine Development | Baylor College of Medicine » speaking at Vaccine Congress USA

Fernanda Boulos, MD, Instituto Butantan

Fernanda Boulos, Chief Medical Officer, Instituto Butantan

Fernanda Boulos | Chief Medical Officer | Instituto Butantan » speaking at Vaccine Congress USA

Abby Bownas, Manager, AVAC ; Partner,, NVG LLC

Charlotte Bradshaw, CEO, Evrima Technologies

Michael Breen, Scientist, Tiba Biotech, LLC

Michael Breen | Scientist | Tiba Biotech, LLC » speaking at Vaccine Congress USA

Oliver Brooks, Chief Medical Officer, Watts Healthcare Corporation

Oliver Brooks | Chief Medical Officer | Watts Healthcare Corporation » speaking at Vaccine Congress USA

Jerry Brown, CEO, John F Kennedy Medical Center

Maarten Brusse, Sr Study Director Preclinical, Cerba Research

Ulrike K Buchwald, Scientific AVP & Pneumococcal Vaccine Section Head Global Clinical Development, Merck & Co

Andrew Burke, Senior Technology Transfer Manager, National Institutes of Health (NIH)

Scott Burris, Professor of Law Director, Center for Public Health Law Research, Temple University Beasley School of Law

Heather Burris, Immunization Division Chief, D.C. Department of Health

Esteban Burrone, Head of Strategy, Policy and Market Access, Medicines Patent Pool

Esteban Burrone | Head of Strategy, Policy and Market Access | Medicines Patent Pool » speaking at Vaccine Congress USA

Lynlee Burton, Vice President, Vaccines, Syneos Health

Lynlee Burton | Vice President, Vaccines | Syneos Health » speaking at Vaccine Congress USA

Jim Buttery, Professor, Child Health Informatics & Co-director, Global Vaccine Safety Network, Murdoch Children's Research Institute, Royal Children's Hospital

Gaurav Byagathvalli, Co-Founder and CEO, Piezo Therapeutics, Inc.

Michael Caldwell, Assoc VP Vaccine Research & Education, Meharry Medical College

Anne-Isabelle Cameron, Strategy Technical Officer, UNITAID

Anne-Isabelle Cameron | Strategy Technical Officer | UNITAID » speaking at Vaccine Congress USA

Adriane Casalotti, Chief of Government and Public Affairs, National Association of County and City Health Officials

Cristina Cassetti, Division Deputy Director, NIH/NIAID

Mariacristina Castelli, Chief Clinical & Regulatory Officer-Noven Pharmaceuticals, Hisamitsu Pharmaceuticals

José Castillo, Chief Executive Officer, Quantoom Biosciences

José Castillo | Chief Executive Officer | Quantoom Biosciences » speaking at Vaccine Congress USA

Andrew Catchpole, CSO, hVIVO

Andrew Catchpole | CSO | hVIVO » speaking at Vaccine Congress USA

Francesca Ceddia, Chief Medical Affairs Officer, Moderna

Rochelle Chaiken, Chief Medical Officer, Vaxxas

Lee-Jah Chang, Head of Clinical Development, Vaccines and Immune Therapies, AstraZeneca

Shoubai Chao, Chief Operating Officer/Executive Director, CanSino Biologics Inc.

Michael Chaplet, Comparability & Characterisation Lead, MSAT Analytical and Material Science, GSK

Michael Chaplet | Comparability & Characterisation Lead, MSAT Analytical and Material Science | GSK » speaking at Vaccine Congress USA

Robert Chen, Scientific Director, Brighton collaboration

Wilbur Chen, Professor of Medicine, University of Maryland School of Medicine

Xi-Lin Chen, Manager, Assay Development, Lab Science, Q² Solutions

Neil Cherian, Senior Biosecurity and R&D Program Manager, C.E.P.I.

Neil Cherian | Senior Biosecurity and R&D Program Manager | C.E.P.I. » speaking at Vaccine Congress USA

Roman Chicz, Global Head Of External Research And Development, Sanofi

Roman Chicz | Global Head Of External Research And Development | Sanofi » speaking at Vaccine Congress USA

Sudha Chivukula, Head Discovery Biology, Sanofi

Spreeha Choudhury, Associate, Epstein Becker & Green

Dennis Christensen, Head of Global R&D, Croda

Lalit Chudal, Senior Formulation Scientist, Jurata Thin Film, Inc.

Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND

James Coburn, Senior Advisor for Emerging Technologies, FDA

Lisa Coen, US Vaccines Policy & Public Affairs Lead, Pfizer, Pfizer

Justin Coen, Partner, Venable LLP

Justin Coen | Partner | Venable LLP » speaking at Vaccine Congress USA

Jamie Coffin, Chief Executive Officer, Nature’s Toolbox, Inc. (NTx)

Jamie Coffin | Chief Executive Officer | Nature’s Toolbox, Inc. (NTx) » speaking at Vaccine Congress USA

Mandy Cohen, Director, CDC

Mandy Cohen | Director | CDC » speaking at Vaccine Congress USA

Wayland Coker, Chief Supply Chain Strategist, DHHS/ASPR

Jeffrey Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics Professor of Molecular Biology and Genetics, Johns Hopkins University

Jeffrey Coller | Bloomberg Distinguished Professor of RNA Biology and Therapeutics Professor of Molecular Biology and Genetics | Johns Hopkins University » speaking at Vaccine Congress USA

Tim Cooke, Chief Executive Officer, Omniose

Lawrence Corey, Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Santiago Cornejo, Executive Manager, Regional Revolving Funds, PAHO

Peter Costa, US Medical Affairs, Bavarian Nordic

Peter Costa | US Medical Affairs | Bavarian Nordic » speaking at Vaccine Congress USA

Chad Costley, Chief Executive Officer, BlueWillow Biologics, Inc.

Aaron Cowley, CSO, ReciBioPharm

Rebecca Coyle, Executive Director, American Immunization Registry Association

Aida Cremesti, Senior Technology Transfer Specialist, Licensing, Collaborations, Clinical Trials, Patenting, National Cancer Institute

Stephen Crooke, Vaccine Immunology Lead, Viral Vaccine Preventable Diseases, Centers for Disease Control and Prevention

James Crowe, Director, Vanderbilt Vaccine Center

Anna Morena D'Alise, VP of Immunology, nouscom

Peter Daszak, President, Ecohealth Alliance Inc.

Barry Datlof, Chief, Business Development and Commercialization, DHA MRDC

Michel de Baar, executive Director, Business Development, MSD

Michel de Baar | executive Director, Business Development | MSD » speaking at Vaccine Congress USA

Mike de Leeuw, Chief Executive Officer, MyLife Technologies BV

Adrianne De Roo, Global Market Access, Valneva Austria GmbH

Adrianne De Roo | Global Market Access | Valneva Austria GmbH » speaking at Vaccine Congress USA

Michel De Wilde, Former Senior Vice President R&D Of Sanofi Pasteur & Owner, MDW Consultant LLC

Candice Decaire, Chief Strategy Officer / General Counsel, Access to Advanced Health Institute

Candice Decaire | Chief Strategy Officer / General Counsel | Access to Advanced Health Institute » speaking at Vaccine Congress USA

Heather Deehan, Director General, Centre for Immunization Readiness, Public Health Agency of Canada

Heather Deehan | Director General, Centre for Immunization Readiness | Public Health Agency of Canada » speaking at Vaccine Congress USA

Joya Delgado Harris, Executive Director, Gold Standard, CEO Roundtable on Cancer

Pete DeMuth, Chief Scientific Officer, Elicio Therapeutics, Inc

Joël Denis, Director General, Centre for Vaccine and Therapeutic Readiness, Public Health Agency Canada

Joël Denis | Director General, Centre for Vaccine and Therapeutic Readiness | Public Health Agency Canada » speaking at Vaccine Congress USA

Cynthia Derdeyn, Professor, Vice Chair of Research, University of Washington

Carmel Devlin, VP Global Regulatory Sciences Vaccines, Pfizer

Carmel Devlin | VP Global Regulatory Sciences Vaccines | Pfizer » speaking at Vaccine Congress USA

Antu Dey, Senior Vice President, Preclinical R&D, Icosavax, Inc

Antu Dey | Senior Vice President, Preclinical R&D | Icosavax, Inc » speaking at Vaccine Congress USA

David Diemert, Professor, The George Washington University

Gary Disbrow, Director, BARDA

Gary Disbrow | Director | BARDA » speaking at Vaccine Congress USA

Jonathan Dodd, Senior Manager, Assay Design and Development, Revvity

Kyle Doolan, Director of Research, Integral Molecular

Kyle Doolan | Director of Research | Integral Molecular » speaking at Vaccine Congress USA

David Dowling, Instructor In Pediatrics, Boston Children's Hospital

William Dowling, Head of Preclinical Development, CEPI

William Dowling | Head of Preclinical Development | CEPI » speaking at Vaccine Congress USA

Cynthia Dukes, Site and Medical Operations, Avacare

Cynthia Dukes | Site and Medical Operations | Avacare » speaking at Vaccine Congress USA

Anna Durbin, Professor, Johns Hopkins Bloomberg School of Public Health

Anna Durbin | Professor | Johns Hopkins Bloomberg School of Public Health » speaking at Vaccine Congress USA

John Dye, Deputy Director of Foundational Sciences, U.S. Army Medical Research Institute of Infectious Diseases

Chris Earnhart, Chief Technology Officer, JPEO-CBRND

Susanne Eder-Lingelbach, VP Clinical Development, Valneva

Michael Egan, CEO/CSO, CastleVax

Amy Elizondo, Chief Strategy Officer, National Rural Health Association

Amy Elizondo | Chief Strategy Officer | National Rural Health Association » speaking at Vaccine Congress USA

Burton Eller, Principal: Public Policy, Advocacy & Legislation, National Grange

Mark Emalfarb, Chief Executive Officer, Dyadic International Inc

Timothy Endy, Disease X and CHIKV Project Leader, CEPI

Emily Erbelding, Director, Microbiology And Infectious Diseases, National Institutes of Health

Emily Erbelding | Director, Microbiology And Infectious Diseases | National Institutes of Health » speaking at Vaccine Congress USA

Aaron Esser-Kahn, Professor, University of Chicago

Costanza Evangelio, Director, Medical Affairs, ICON PLC

Jay Evans, Chief Scientific and Strategy Officer, Inimmune

Katie Ewer, Sr Project Leader, malaria vaccines, GSK

Brent Ewig, Chief of Policy & Government Relations, Association of Immunization Managers

Rebecca Farkas, Director, R&D Innovations, CEPI

Philip Felgner, Director, Vaccine R&D Center, University of California at Irvine

Amy Finan, Chief Executive Officer, Sabin Vaccine Institute

Alessandra Fix, Associate Principal, Alessandra

Temi Folaranmi, Vice President, US Medical Affairs, GSK

Dean Albert Follmann, Chief, Biostatistics Research Branch, National Institute of Health - NIAID

Robert Forgey, President & Chief Executive Officer, Iaso Therapeutics, Inc.

Caroline Forkin, Head of Clinical Development Programmes and Operations, CEPI

Caroline Forkin | Head of Clinical Development Programmes and Operations | CEPI » speaking at Vaccine Congress USA

Eduardo Forleo-Neto, VP, Vaccine Clinical Research & Development, Pfizer

Eduardo Forleo-Neto | VP, Vaccine Clinical Research & Development | Pfizer » speaking at Vaccine Congress USA

Nicole Frahm, Head of Biomarker Development, Bill & Melinda Gates Medical Research Institute

Nicole Frahm | Head of Biomarker Development | Bill & Melinda Gates Medical Research Institute » speaking at Vaccine Congress USA

Stephen Framil, Corporate Global Head of Accessibility, Merck & Co. Inc.

Leonard Friedland, VP, Medical Affairs, GSK

Leonard Friedland | VP, Medical Affairs | GSK » speaking at Vaccine Congress USA

Stine Friis, Director, Evaxion Biotech A/S

Stine Friis | Director | Evaxion Biotech A/S » speaking at Vaccine Congress USA

Hristu Gache, Global Lead, Vaccines, Bavarian Nordic

Hristu Gache | Global Lead, Vaccines | Bavarian Nordic » speaking at Vaccine Congress USA

Sunil Gairola, Executive Director, Serum Institute of India Ltd

Sunil Gairola | Executive Director | Serum Institute of India Ltd » speaking at Vaccine Congress USA

Marco Gallotta, Life Science Analyst, Airfinity

Gian Gandhi, Deputy Director, Vaccine Access, Immunization Program Strategy Team, B.M.G.F.

Claudia-Nanette Gann, Vice President Clinical Development, BioNTech

Claudia-Nanette Gann | Vice President Clinical Development | BioNTech » speaking at Vaccine Congress USA

Pete Gardner, Research Lead, Antibodies & Immunity, Wellcome Trust

Pete Gardner | Research Lead, Antibodies & Immunity | Wellcome Trust » speaking at Vaccine Congress USA

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Cyril Gay | Senior National Program Leader | A.R.S. National Programs » speaking at Vaccine Congress USA

Andrew Geall, Chief Development Officer, Replicate Bioscience, Inc.

Huub Gelderblom, Director of Strategic Partnerships, HVTN and CoVPN, fred hutch

Bruce Gellin, SVP and Chief, Global Public Health Strategy, The Rockefeller Foundation

Bruce Gellin | SVP and Chief, Global Public Health Strategy | The Rockefeller Foundation » speaking at Vaccine Congress USA

Rebecca Gentile, Associate Principal Scientist, Merck

Asha George, Executive Director, Bipartisan Commission on Biodefense

Asha George | Executive Director | Bipartisan Commission on Biodefense » speaking at Vaccine Congress USA

Sue Gerber, Expert and Epidemiologist, Acasus

Sue Gerber | Expert and Epidemiologist | Acasus » speaking at Vaccine Congress USA

Elodie Ghedin, Senior Investigator, National Institute of Health - NIAID

Elodie Ghedin | Senior Investigator | National Institute of Health - NIAID » speaking at Vaccine Congress USA

Trang Gisler, Senior Director, Government and Public Health Services, PPD, part of Thermo Fisher Scientific

Trang Gisler | Senior Director, Government and Public Health Services | PPD, part of Thermo Fisher Scientific » speaking at Vaccine Congress USA

Jacob Glanville, Chief Executive Officer, Centivax

Zelanna Goldberg, Chief Medical Officer, Replicate Bioscience, Inc.

Sebastian Goy, Chief Operating Officer, EBViously

Sebastian Goy | Chief Operating Officer | EBViously » speaking at Vaccine Congress USA

Shannon Greene, Program Manager, DARPA

Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI

Marion Gruber | Vice President of Public Health and Regulatory Affairs | IAVI » speaking at Vaccine Congress USA

Farshad Guirakhoo, CSO, Expres2ion Biotechnologies Aps

Anuradha Gupta, President of Global Immunization, Sabin Vaccine Institute

Swati Gupta, VP, Head of Emerging Infectious Diseases and Epidemiology, International AIDS Vaccine Initiative

Swati Gupta | VP, Head of Emerging Infectious Diseases and Epidemiology | International AIDS Vaccine Initiative » speaking at Vaccine Congress USA

Emily Gurley, Distinguished Professor of The Practice, Johns Hopkins Bloomberg School of Public Health

Alejandra Gurtman, Sr VP, Vaccines Clinical R&D, Pfizer

Alejandra Gurtman | Sr VP, Vaccines Clinical R&D | Pfizer » speaking at Vaccine Congress USA

Bassam Hallis, Deputy Director, Research and Evaluation, UK Health Security Agency

Bassam Hallis | Deputy Director, Research and Evaluation | UK Health Security Agency » speaking at Vaccine Congress USA

Michinari Hamaguchi, Director General, AMED SCARDA

Michinari Hamaguchi | Director General | AMED SCARDA » speaking at Vaccine Congress USA

Peggy Hamburg, Co-President, The InterAcademy Partnership & Former US FDA Commissioner, The InterAcademy Partnership

Peggy Hamburg | Co-President, The InterAcademy Partnership & Former US FDA Commissioner | The InterAcademy Partnership » speaking at Vaccine Congress USA

Melinda Hamer, Health Security Fellow, Global Health Investment Corporation

Chandresh Harjivan, Special Assistant to the President, Domestic Preparedness and Response to Biological Threats, Office of Pandemic Preparedness and Response Policy (OPPR), Executive Office of The President (EOP)

Chandresh Harjivan | Special Assistant to the President, Domestic Preparedness and Response to Biological Threats | Office of Pandemic Preparedness and Response Policy (OPPR), Executive Office of The President (EOP) » speaking at Vaccine Congress USA

Rebecca Harston, Executive Director, Business Development, Government and Public Health Services, PPD, part of Thermo Fisher Scientific

Renee Hart, President & CBO, LumaCyte

Renee Hart | President & CBO | LumaCyte » speaking at Vaccine Congress USA

Philippa Harvey, Director - COVID Vaccines Unit, UK Health Security Agency

Philippa Harvey | Director - COVID Vaccines Unit | UK Health Security Agency » speaking at Vaccine Congress USA

Bill Hausdorff, Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and, Center for Vaccine Innovation and Access, PATH

Anne Hause, Epidemiologist, CDC

Jason He, Executive Director, Head of CMC Management, WuXi Biologics

Biao He, Chief Executive Officer, Blue Lake Biotechnology

Penny Heaton, Global Therapeutic Area Head, Vaccines, Janssen Pharmaceutical companies of Johnson & Johnson

Penny Heaton | Global Therapeutic Area Head, Vaccines | Janssen Pharmaceutical companies of Johnson & Johnson » speaking at Vaccine Congress USA

Andrew Hebbeler, Principa Assistant Director for Health and Life Science, White House Office Of Science And Technology Policy (OSTP)

Andrew Hebbeler | Principa Assistant Director for Health and Life Science | White House Office Of Science And Technology Policy (OSTP) » speaking at Vaccine Congress USA

Colin Hebert, SVP, Scientific & Business Operations, LumaCyte

Colin Hebert | SVP, Scientific & Business Operations | LumaCyte » speaking at Vaccine Congress USA

Bradlee Heckmann, Assistant Prof, USF Health Neuroscience Institute & Morsani College of Medicine; Scientific Co-Founder, Asha Therapeutics

Jonathan Heeney, Chief Executive Officer, DIOSynVax Limited

Jonathan Heeney | Chief Executive Officer | DIOSynVax Limited » speaking at Vaccine Congress USA

Jon Heinrichs, Vice President, Antibody Program Strategy and Translational Immunology, International AIDS Vaccine Initiative

Grant Henderson, Senior Director, Commercial & Technical Operations, Vernal Biosciences

Jennifer Hendriks, Head Biomarkers and Clinical Immunology, Janssen Vaccines & Prevention B.V.

Jennifer Hendriks | Head Biomarkers and Clinical Immunology | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Lisa Hensley, Distinguished Senior Research Scientist Research Lead - Zoonotic and Emerging Disease Research Unit, USDA

Lisa Hensley | Distinguished Senior Research Scientist Research Lead - Zoonotic and Emerging Disease Research Unit | USDA » speaking at Vaccine Congress USA

Matthew Hepburn, Chief Medical Officer, JPEO-CBRND

Matthew Hepburn | Chief Medical Officer | JPEO-CBRND » speaking at Vaccine Congress USA

Jaime E Hernandez, Executive Medical Director, Clinical Development, Syneos Health

Jaime E Hernandez | Executive Medical Director, Clinical Development | Syneos Health » speaking at Vaccine Congress USA

Adrian Hill, Director and Professor, The Jenner Institute - University of Oxford

Roy Himawan, Director of Pharmaceuticals and Medical Device Resilience, Ministry of Health Republic of Indonesia

Tim Hirst, CEO, GPN Vaccines

Tim Hirst | CEO | GPN Vaccines » speaking at Vaccine Congress USA

Arthur Hirt, Senior Vice President, Vaccines Business Unit, Merck

Arthur Hirt | Senior Vice President, Vaccines Business Unit | Merck » speaking at Vaccine Congress USA

Cathy Hoath, Regulatory Affairs Strategy Lead, CEPI

David Hoey, Chief Executive Officer, Vaxxas

Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria

Stephen Hoffman | Chief Executive And Scientific Officer | Sanaria » speaking at Vaccine Congress USA

Kyle Holen, SVP, Head of Development, Therapeutics and Oncology, Moderna

David Hoover, IDSAB Member, Integrum Scientific

Bob Hopkins, Medical Director, National Foundation for Infectious Diseases

Peter Hotez, Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center for Vaccine Development, Baylor college of medicine

Chris Houchens, Director, Division CBRN MCMs, BARDA

Chris Houchens | Director, Division CBRN MCMs | BARDA » speaking at Vaccine Congress USA

Richard Hughes IV, Partner, Epstein, Becker & Green, The George Washington University Law School

David Humphreys, Global Head of Health Policy, Economist Impact

Christopher Hunter, Distinguished Professor Of Pathobiology, University of Pennsylvania

Hitesh Hurkchand, Senior Child Health and Immunization Program Manager, USAID

Hitesh Hurkchand | Senior Child Health and Immunization Program Manager | USAID » speaking at Vaccine Congress USA

Christina Hutson, Chief, Poxvirus and Rabies Branch, CDC

Christina Hutson | Chief, Poxvirus and Rabies Branch | CDC » speaking at Vaccine Congress USA

Jens Ibsen, Application Scientist, Studylog System Inc

Tetsuro Ikegami, Professor, University of Texas Medical Branch

Rebecca Ingram, Senior Lecturer, Queen's University Belfast

Peta-Gay Jackson Booth, Principal Investigator, Care Access

Peta-Gay Jackson Booth | Principal Investigator | Care Access » speaking at Vaccine Congress USA

Anna Jacobs, Biologist, BARDA

Juan Carlos Jaramillo, Chief Medical Officer, Valneva

Juan Carlos Jaramillo | Chief Medical Officer | Valneva » speaking at Vaccine Congress USA

Courtney Jarrahian, Director, Delivery Technologies, PATH

Lakshmi Jayashankar, Biologist, BARDA

Lakshmi Jayashankar | Biologist | BARDA » speaking at Vaccine Congress USA

John Jernigan, Chief, Epidemiology Research and Innovations Branch, Division of Healthcare Quality Promotion, CDC

William Jia, Chief Scientific Officer, ViroGin Biotech

Nafisa Jiwani, Managing Director, Development Finance Corporation

Karin Jooss, EVP and Head of Research and Development, Gritstone Bio

Arlene Joyner, Director, Office of Industrial Base Management and Supply Chain (IBMSC),, HHS/.ASPR/IBMSC

Chantale Julien, Product Manager, Novo Nordisk Pharmatech A/S

Chantale Julien | Product Manager | Novo Nordisk Pharmatech A/S » speaking at Vaccine Congress USA

Raj Kalkeri, Translational Medicine Lead, Novavax

Raj Kalkeri | Translational Medicine Lead | Novavax » speaking at Vaccine Congress USA

Esper Georges Kallás, Director, Instituto Butantan

Walid Kandeil, Global Medical Lead, Takeda

Krishna Kannan, Senior Director of Product Development, Telesis Bio

Maria Karasarides, Former Vice President, Head of Early Assets and Biomarkers, Bristol Myers Squibb

Maria Karasarides | Former Vice President, Head of Early Assets and Biomarkers | Bristol Myers Squibb » speaking at Vaccine Congress USA

Nektaria Karavas, Business Development Director, Aptar Pharma

Nektaria Karavas | Business Development Director | Aptar Pharma » speaking at Vaccine Congress USA

David Kaslow, Office Director, FDA

David Kaslow | Office Director | FDA » speaking at Vaccine Congress USA

Anne Kasmar, SVP Global Therapeutic Area Head, Infectious, Parexel

Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Hans Keirstead | Chief Executive Officer | AIVITA Biomedical, Inc. » speaking at Vaccine Congress USA

Edward Kelley, Chief Global Health Officer, ApiJect

Chase Kempinski, Chief Executive Officer, Enepret

Vacheria Keys, Associate Vice President, Policy & Regulatory Affairs, National Association of Community Health Centers Inc

Amin Khan, Icosavax, Inc

Amin Khan |  | Icosavax, Inc » speaking at Vaccine Congress USA

Kamran Khan, Founder & Chief Executive Officer, BlueDot

Anjalee Khemlani, Senior Reporter, Yahoo! Finance

Alena Khromava, Therapeutic Area Strategic Lead, Vaccine GBU and Patient Safety and Pharmacovigilance Department, Sanofi

Alena Khromava | Therapeutic Area Strategic Lead, Vaccine GBU and Patient Safety and Pharmacovigilance Department | Sanofi » speaking at Vaccine Congress USA

Andrew Kilianski, Program Manager, ARPA-H

Andrew Kilianski | Program Manager | ARPA-H » speaking at Vaccine Congress USA

Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp

Kevin Killeen | Chief Scientific Officer | Matrivax R & D Corp » speaking at Vaccine Congress USA

Kevin Killeen, CSO, Matrivax

Kevin Killeen | CSO | Matrivax » speaking at Vaccine Congress USA

HUN KIM, President, SK bioscience

Jerome Kim, Director General, IVI

Thomas King, VP of Nonclinical R&D, Sabin Vaccine Institute

Tara Kirby, Director, Office of Technology Transfer, National Institutes of Health

Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience

Harry Kleanthous | Executive Vice President, Vaccines R&D Strategy & External Innovation | SK Bioscience » speaking at Vaccine Congress USA

Charles Kline, Associate Vice President, Merck

Dinah Knotts-Keeterle, Vice President, Project Management, Vaccines and Infectious Diseases, ICON PLC

Russell Kowalczyk, Chief Commercial Officer, ApiJect

Phil Krause, Advisor, WHO

Phil Krause | Advisor | WHO » speaking at Vaccine Congress USA

Amit Kumar, Chief Executive Officer, Anixa Biosciences

Mahesh Kumar, Senior VP, Global Biologics R&D, Zoetis

Prabuddha Kundu, Cofounder & Managing Director, Premas Biotech

Prabuddha Kundu | Cofounder & Managing Director | Premas Biotech » speaking at Vaccine Congress USA

Erik Lamberth, Senior Director of Vaccine Clinical Research and Development, Pfizer

Erik Lamberth | Senior Director of Vaccine Clinical Research and Development | Pfizer » speaking at Vaccine Congress USA

Nathalie Landry, Chief Scientific Officer, PharmaJet

Miriam Laufer, Professor of Pediatrics Malaria Research Program Director, University Of Maryland, Center For Vaccine Development and Global Health

Miriam Laufer | Professor of Pediatrics Malaria Research Program Director | University Of Maryland, Center For Vaccine Development and Global Health » speaking at Vaccine Congress USA

Paul Lawrence, Director of Research and Development, Bimeda

Alexandre Le Vert, Chief Executive Officer, Osivax

Gigi Lefebvre, Principal Investigator, Care Access

Gigi Lefebvre | Principal Investigator | Care Access » speaking at Vaccine Congress USA

Matthew Leibovitch, Senior Scientist - Assay Development, Q2 Solutions

Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Health - NIAID

Paul Leon, Head of Government & NGO Strategy, AstraZeneca Pharmaceuticals

Hanna Lesch, CTO, Exothera

Orin Levine, Non Resident Fellow, Center for Global Development

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Dave Liebowitz, Senior Vice President, Early-Stage Clinical Development, Inovio

Christopher Lim, Chief, Strategic Funds, Pan American Health Organization (PAHO), WHO

Christopher Lim | Chief, Strategic Funds, Pan American Health Organization (PAHO) | WHO » speaking at Vaccine Congress USA

Thomas Lingelbach, President & CEO, Valneva

Thomas Lingelbach | President & CEO | Valneva » speaking at Vaccine Congress USA

C. Malcolm Little, Principal, Arlington Capital Partners

C. Malcolm Little | Principal | Arlington Capital Partners » speaking at Vaccine Congress USA

Fernando Lobos, Director, sinergium biotech

Kristina Lorenson, Senior Contract Manager, UNICEF

Kristina Lorenson | Senior Contract Manager | UNICEF » speaking at Vaccine Congress USA

Jonathan Lovell, Co-founder, POP Biotechnologies, Inc.

Yun Lu, Mathematical Statistician, U.S. Food and Drug Administration

Blair Lucas, Group Commercial Director, Acclime Australia

Matthew Lucia, Director, Office of New Animal Drug Evaluation, FDA

Brooke Luck, BioMaP Program Manager, BARDA

Brooke Luck | BioMaP Program Manager | BARDA » speaking at Vaccine Congress USA

Martin Lukac, Chief Technology Officer, Nexleaf Analytics

Catherine Lund, managing Director, OnQ Research

Catherine Lund | managing Director | OnQ Research » speaking at Vaccine Congress USA

Nicole Lurie, Executive Director of Prepardness and Response, CEPI-US

Nicole Lurie | Executive Director of Prepardness and Response | CEPI-US » speaking at Vaccine Congress USA

Angela Luttick, EVP Commercial, 360biolabs

Fadi Makki, Partner and Director, Boston Consulting Group

Shelly Malhotra, Executive Director, Global Access, IAVI

Shelly Malhotra | Executive Director, Global Access | IAVI » speaking at Vaccine Congress USA

Raburn Mallory, SVP of Clinical Development, Novavax

Alessandro Manenti, Chief Development Officer, VisMederi Research Srl

Alessandro Manenti | Chief Development Officer | VisMederi Research Srl » speaking at Vaccine Congress USA

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (CBER) | U.S. Food and Drug Administration » speaking at Vaccine Congress USA

Christopher P Marshall, Founder and Chief Executive Officer, Calder Biosciences Inc.

Beth Marshall, Medical Director, Parexel

David Martin, Vice President, Global Head RWE, Medical, Moderna

David Martin | Vice President, Global Head RWE, Medical | Moderna » speaking at Vaccine Congress USA

Laura Martin, Vaccines Program Director, Global Health Technical Programs, USP

John Mascola, CSO, ModeX Therapeutics

Rashad Massoud, Visiting Lecturer, Harvard T.H. Chan School of Public Health

Rashad Massoud | Visiting Lecturer | Harvard T.H. Chan School of Public Health » speaking at Vaccine Congress USA

Michael Matthews, Director, Regulatory Affairs, Sabin Vaccine Institute

Luciana Maxim, Director, Quality and Impact, VillageReach

Diane McCarthy, Senior Director, Global Biologics, U.S. Pharmacopeia

Bruce McClenathan, Executive Medical Director, Allucent

Bill Mcgillian, Associate Engineering Director, Merck

Bill Mcgillian | Associate Engineering Director | Merck » speaking at Vaccine Congress USA

Kyle McGowan, Access to Advanced Health Institute

Kyle McGowan |  | Access to Advanced Health Institute » speaking at Vaccine Congress USA

Justine McPartlan, Scientist I, Tiba Biotech

Mauricio Mendonça Jorge, Public Affairs Director, Sanofi Medley Farmacêutica Ltda

Mauricio Mendonça Jorge | Public Affairs Director | Sanofi Medley Farmacêutica Ltda » speaking at Vaccine Congress USA

Nelson Michael, Director, Center for Infectious Diseases Research, Walter Reed Army Institute of Research

Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader, GVGH

Michael Miller, Consultant, Advisor & Coach, HealthPolCom

Jacqueline Miller, Senior Vice President and Therapeutic Area Head of Infectious Disease, Moderna Therapeutics

Benedict Millinchip, Senior Lead, Global Health Security (Vaccines), World Health Organisation

Jules Millogo, Director of Public Health Partnerships, Merck

Rowan Milner, Professor of Oncology Director of Clinical and Translational Research, University of Florida

Rachel Mitrovich, Director, Global Vaccines Public Policy, Merck

Rachel Mitrovich | Director, Global Vaccines Public Policy | Merck » speaking at Vaccine Congress USA

Kayvon Modjarrad, Executive Director, Viral Vaccines, Pfizer

Kayvon Modjarrad | Executive Director, Viral Vaccines | Pfizer » speaking at Vaccine Congress USA

Lenny Moise, VP, Research, SeromYx

Tina Morgenstein, Project Director in the Vaccine Therapeutic Unit, PPD, Part of Thermo Fisher Scientific

Tina Morgenstein | Project Director in the Vaccine Therapeutic Unit | PPD, Part of Thermo Fisher Scientific » speaking at Vaccine Congress USA

Lisa Morici, Professor, Tulane University School of Medicine

Kaitlyn Morse, Chief Executive Officer, VaxSyna INC.

Phil Morton, Chief Technology Officer, Albumedix Ltd. - NOTTINGHAM

Synovia Moss, National Project Manager, NCNW Good Health WINs

Steffen Mueller, Chief Scientific Officer, Codagenix Inc.

Steffen Mueller | Chief Scientific Officer | Codagenix Inc. » speaking at Vaccine Congress USA

Zeshan Muhammedi, MBX Capital

Zeshan Muhammedi |  | MBX Capital » speaking at Vaccine Congress USA

Piyali Mukherjee, Vice President Head Medical Affairs, gsk

Piyali Mukherjee | Vice President Head Medical Affairs | gsk » speaking at Vaccine Congress USA

Anne Mullin, Principal, Shift Health

Anne Mullin | Principal | Shift Health » speaking at Vaccine Congress USA

Iona Munjal, Executive Director, Vaccine Clinical Research and Development, Pfizer

Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS

Rustam Nabiev, Director, Shifo Foundation

Farooq Nasar, Senior Principal Investigator, Research and Development Center, Tonix Pharma

Joshua Nealon, Medical lead: Pre-licensure Flu and COVID-19 vaccines, Sanofi Vaccines

Joshua Nealon | Medical lead: Pre-licensure Flu and COVID-19 vaccines | Sanofi Vaccines » speaking at Vaccine Congress USA

Kathleen Neuzil, Director - Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Judith Neville, Director, Project Mgmt, Vaccines, PPD, Part of Thermo Fisher Scientific

Mark Newman, Chief Scientific Officer, GeoVax Labs, Inc.

Chime Nnadi, R&D, Sanofi

Brett Noel, Senior Associate, RA Capital

Dale Nordenberg, Digital Health Lead, Brighton collaboration

Kevin O'Brien, Vice President & Global Head of Allergy Respiratory and Infectious Diseases & Vaccines Centers, IQVIA

Comfort Ogar, Senior Pharmacovigilance Manager, USP

Latifat Okara, Principal, Health Policy & Insights, Economist Impact

Folake Olayinka, Immunization Technical Lead, Global Health Bureau,, USAID

Isabel Oliver, Director General of Science & Research and Chief Scientific Officer, UK Health Security Agency

Dinja Oosterhoff, VP R&D, Intravacc

Dinja Oosterhoff | VP R&D | Intravacc » speaking at Vaccine Congress USA

Barbara Pahud, Director, Pfizer

Barbara Pahud | Director | Pfizer » speaking at Vaccine Congress USA

Peter Palese, Professor And Chair Microbiology, Mount Sinai School of Medicine

Peter Palese | Professor And Chair Microbiology | Mount Sinai School of Medicine » speaking at Vaccine Congress USA

Gaurav Pandey, Head Of Vaccine Process Development, International Vaccine Institute

Gaurav Pandey | Head Of Vaccine Process Development | International Vaccine Institute » speaking at Vaccine Congress USA

Vikram Paradkar, Senior Vice President, Technical Operations, Biological E Limited

Rachel Park, Director International Business Development, EuBiologics Co

Sandeep Patel, Director of BARDA Division of Research, Innovation, and Ventures (DRIVe)Director of BARDA Division of Research, Innovation, and, HHS/BARDA

Sandeep Patel | Director of BARDA Division of Research, Innovation, and Ventures (DRIVe)Director of BARDA Division of Research, Innovation, and | HHS/BARDA » speaking at Vaccine Congress USA

Mayur Patel, VP Global R&D Product Development and Portfolio Management, Elanco

Anita Patel, Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences

Heenal Patel, Commercial Lead, PARATUS CLINICAL

Anant Patkar, Senior Director, Technical and Business Operations, Primrose BIo

Bryan Patterson, Senior Director, Strategic Proposal Development and Strategy, PPD, Part of Thermo Fisher Scientific

Georgina Peacock, Director, Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention

Daniel Peréz, Georgia Research Alliance Distinguished Investigator and Caswell Eidson Chair in Poultry Medicine, University of Georgia College of Veterinary Medecine

Sallie Permar, Chair of Pediatrics, Weill Cornell Medical College

Sallie Permar | Chair of Pediatrics | Weill Cornell Medical College » speaking at Vaccine Congress USA

Susan Peschin, President and Chief Executive Officer, Alliance for Aging Research

Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)

Waranyoo Pang Phoolcharoen, CTO, Baiya Phytopharm Co., Ltd.

Michael Piazza, Director, Applications Development, nicoya

Jessica Pickett, Director, US Vaccines Health Economics and Outcomes Research, GSK

Tamara Pilishvili, Medical Director, US Medical and Clinical Affairs Lead, Pneumococcal MAPS Vaccines, GSK

Tamara Pilishvili | Medical Director, US Medical and Clinical Affairs Lead, Pneumococcal MAPS Vaccines | GSK » speaking at Vaccine Congress USA

Guy R. Pilkington, Senior Scientist Virology, ATCC

Guy R. Pilkington | Senior Scientist Virology | ATCC » speaking at Vaccine Congress USA

Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic

Gregory Poland | Director of Mayo Vaccine Research Group | Mayo Clinic » speaking at Vaccine Congress USA

Michael Pollack, Supervisory Technology Transfer Manager, National Institutes of Health (NIH)

Christopher Poon, Director, CMC Lead, Emergent BioSolutions

Leo Poon, Professor And Division Head Of Public Health Laboratory Sciences, The University of Hong Kong

Robert Popovian, Chief Science Policy Officer, Global Healthy Living Foundation

Chad Porter, Department Head, Translational and Clinical Research, Naval Medical Research Center

Marco Pravetoni, Center Director & Rick L. Seaver Endowed Professor of Psychiatry, University of Washington School of Medicine

Martin Rabel, Services Solutions Specialist, Cytiva

Martin Rabel | Services Solutions Specialist | Cytiva » speaking at Vaccine Congress USA

Trina Racine, Director Vaccine Development, Vaccine and Infectious Disease Organization (VIDO)

Paul Radspinner, Chief Executive Officer, FluGen Inc

Paul Radspinner | Chief Executive Officer | FluGen Inc » speaking at Vaccine Congress USA

Izabela Ragan, Director of Research and Development, Solaris Vaccines

Gowrisankar Rajam, Principal Scientist, PDMB (Bioanalytics), Merck Research Laboratories

Irina Ramos, Director, Bioprocess Technologies & Engineering, AstraZeneca

Irina Ramos | Director, Bioprocess Technologies & Engineering | AstraZeneca » speaking at Vaccine Congress USA

Mitsu Rana, Senior Director, Project Management, ICON PLC

Montrece Ransom, Director, The National Coordinating Center for Public Health Training

Montrece Ransom | Director | The National Coordinating Center for Public Health Training » speaking at Vaccine Congress USA

Rachel Rath, BARDA Alliance Director, Johnson & Johnson Innovation

Lauren Rauh, Director of Programs, Cuny School of Public Health

Denise Reaves, Senior Analytical Scientist, Jurata Thin Film, Inc.

John Redd, Chief Medical Officer, The Medical Countermeasures Coalition

Ian Rentsch, CCO & GM Pharma, Centogene

Ian Rentsch | CCO & GM Pharma | Centogene » speaking at Vaccine Congress USA

Nikos Reppas, Senior Director, Foundry Technology, Gingko Bioworks

MaryLisabeth Rich, President, CEO Roundtable on Cancer

Megan Riley, Director of Scientific For Rsv Adult Vaccine, GSK

Megan Riley | Director of Scientific For Rsv Adult Vaccine | GSK » speaking at Vaccine Congress USA

Julie Riley, Regulatory and Policy Strategist, American Academy of Family Physicians

Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE

Edward J Robb, Chief Strategy Officer, Anivive Lifesciences

Michelle Roberts, Global Medical Franchise Head , RSV, Vaccines, Sanofi

Michelle Roberts | Global Medical Franchise Head , RSV, Vaccines | Sanofi » speaking at Vaccine Congress USA

Josh Robinson, Chief Executive Officer, COCOON BIOSCIENCE

Tiago Rocca, Director of Strategic Partnerships and Business Development, Instituto Butantan

Mario Rodriguez, Senior Director Medical Affairs, Emergent BioSolutions

Diana Rojas Alvarez, Technical Lead – Zika & Chikungunya, World Health Organisation

Diana Rojas Alvarez | Technical Lead – Zika & Chikungunya | World Health Organisation » speaking at Vaccine Congress USA

Nikki Romanik, Special Assistant to the President, Deputy Director and Chief of Staff, Office of Pandemic Preparedness and Response Policy (OPPR), Executive Office of The President (EOP)

Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines

Birgitte Rønø, Chief Scientific Officer, Evaxion Biotech A/S

Zeil Rosenberg, Executive Vice President, Medical, Tonix Pharmaceuticals

Andres Rozo, Executive Director, Vaccine eTools for Clinical Trials, Integra IT

Andres Rozo | Executive Director, Vaccine eTools for Clinical Trials | Integra IT » speaking at Vaccine Congress USA

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.

Jerald Sadoff | Senior Advisor Vaccine Development | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Jerald Sadoff, Chief Medical Officer, Centivax

Jerald Sadoff | Chief Medical Officer | Centivax » speaking at Vaccine Congress USA

Sushant Sahastrabuddhe, Deputy Director General, International Vaccine Institute

Sushant Sahastrabuddhe | Deputy Director General | International Vaccine Institute » speaking at Vaccine Congress USA

Neil Sahota, UN AI Advisor & IBM Master Inventor, United Nations

Michael Salgaller, Assistant Director, Technology Transfer Center, National Institutes of Health (NIH)

Michael Salgaller | Assistant Director, Technology Transfer Center | National Institutes of Health (NIH) » speaking at Vaccine Congress USA

Amadou Sall, CEO, Institut Pasteur de Dakar

Amadou Sall | CEO | Institut Pasteur de Dakar » speaking at Vaccine Congress USA

Daniel Salmon, Director, Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Vitalie Samoil, Associate Director of Protein Science, Q² Solutions (Now Nexelis)

Tyler Sandberg, Product Manager, ELISpot & FluoroSpot, Mabtech

Gustavo Mendes Lima Santos, Director of Regulatory, Quality Control and Clinical Studies, Instituto Butantan

Michael Santos, Senior Vice President and Chief Population Health Science Officer, FNIH

Thais Dos Santos, Advisor, Epidemic Alert and Response, PAN AMERICAN HEALTH ORGANIZATION

Thais Dos Santos | Advisor, Epidemic Alert and Response | PAN AMERICAN HEALTH ORGANIZATION » speaking at Vaccine Congress USA

Gautam Sanyal, Principal Consultant, Vaccine Analytics, LLC, USA

Niranjan Sardesai, President & Chief Executive Officer, Founder, Geneos Therapeutics

Dona Sarkar, Director, Microsoft for Copilot

Leena Scaria, Director, U.S. Vaccine Public Policy, Merck & Co., Inc.

Leena Scaria | Director, U.S. Vaccine Public Policy | Merck & Co., Inc. » speaking at Vaccine Congress USA

Brian Schanen, Global Head of Biomarkers, Sanofi

Steven Schmid, Sr. Director, Laboratory Strategic Planning and Development, Flourish Research

Katherine Schultheis, Head of Discovery Research, ACM Biosciences

Katherine Schultheis | Head of Discovery Research | ACM Biosciences » speaking at Vaccine Congress USA

Michael Schunk, Senior Vaccine Industry Specialist, International Finance Corporation -WBG

Sarit Schwartz, Head of RNA, Business Development, Ginkgo Bioworks

Darin Seehafer, Chief Commercial Officer, Integra IT

Bret Sellman, Head of Bacterial Vaccines, AstraZeneca

Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology

Randall Severance, Director Medical Operations, AES Corporation

Randall Severance | Director Medical Operations | AES Corporation » speaking at Vaccine Congress USA

Taylor Sexton, Executive Director, Medical Countermeasures Coaltion

Rachel Sha, Interim CEO, Vaxess Technologies

Rachel Sha | Interim CEO | Vaxess Technologies » speaking at Vaccine Congress USA

Umesh Shaligram, Executive Director and Head of R&D, Serum Institute of India Ltd

Umesh Shaligram | Executive Director and Head of R&D | Serum Institute of India Ltd » speaking at Vaccine Congress USA

Gopi Shanker, CSO, Beam Therapeutics

Jonathan Shepherd, Director, Project Leadership, Parexel

Lindsey Shields, Deputy Director, Epidemic Prepardness and Response, PATH

Lora Shimp, Director - Immunization Center, John Snow Inc

Amy Shrank, Principal, ZS Associates

Amy Shrank | Principal | ZS Associates » speaking at Vaccine Congress USA

Brianna Skinner, Senior Regulatory Veterinarian, FDA

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

Stephen Spagnol, Director, Business Development & Licensing, Merck

Erin Sparrow, Technical Officer, Vaccine Product and Delivery Research, World Health Organisation

Erin Sparrow | Technical Officer, Vaccine Product and Delivery Research | World Health Organisation » speaking at Vaccine Congress USA

Jonathan Stambolis, CEO, Zenysis

Mike Stebbins, Vice President, Medical CBRN Defense Consortium (MCDC)

Mike Stebbins | Vice President | Medical CBRN Defense Consortium (MCDC) » speaking at Vaccine Congress USA

Andrew Steer, Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, The Royal Children's Hospital, Melbourne

Andrew Steer | Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group | The Royal Children's Hospital, Melbourne » speaking at Vaccine Congress USA

Richard Stratford, Co-Founder and Advisor, NEC OncoImmunity AS

Richard Stratford | Co-Founder and Advisor | NEC OncoImmunity AS » speaking at Vaccine Congress USA

Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics

Vic Suarez, Founder & Principal Growth Partner, BluZoneBio

Ashim Subedee, Director, Catalyst Office, Biomedical Advanced Research and Development Authority (BARDA)

Adriana Suenaga, Director, Integrated Solution Strategist, Parexel

Adriana Suenaga | Director, Integrated Solution Strategist | Parexel » speaking at Vaccine Congress USA

Julie Suman, Vice President, Scientific Affairs, Aptar Pharma

Julie Suman | Vice President, Scientific Affairs | Aptar Pharma » speaking at Vaccine Congress USA

Michael Sumner, Chief Medical Officer, Inovio Pharmaceuticals

Rajinder Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers Network

Rajinder Suri | Chief Executive Officer | Developing Countries Vaccine Manufacturers Network » speaking at Vaccine Congress USA

Nigel Swift, Head of Sustainable Agriculture and One Health, Dalan Animal Health

Adel Talaat, Professor Of Microbiology, University of Wisconsin-Madison

Litjen Tan, Chief Strategy Officer, Immunization Action Coalition

Litjen Tan | Chief Strategy Officer | Immunization Action Coalition » speaking at Vaccine Congress USA

Milagritos Tapia, Professor of Pediatric Infectious Diseases, university of maryland

Kimberly Taylor, Senior Scientific Officer, Concept Acceleration Program - Vaccines, NIH

Petro Terblanche, Chief Executive Officer, Afrigen Biologics (Pty) Ltd

Petro Terblanche | Chief Executive Officer | Afrigen Biologics (Pty) Ltd » speaking at Vaccine Congress USA

Steven Theriault, Chief Executive Officer & Chief Science Officer, Cytophage Technologies

Patrick Thiaville, CTO, Exothera

Stephen Thomas, Chair, Department of Microbiology & Immunology, Suny Upstate Medical University Hospital

Stephen Thomas | Chair, Department of Microbiology & Immunology | Suny Upstate Medical University Hospital » speaking at Vaccine Congress USA

Angus Thomson, Principal, Irimi

Emily Tiemann, Manager, Health Policy & Insights, Economist Impact

Thomas Tillett, Chief Executive Officer, MBF Therapeutics

Georgia Tomaras, Director, Center for Human Systems Immunology, Duke University

Karina Top, Professor, University of Alberta

Alexa Trost, Senior Consultant, Access Partnership

Jane True, VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer

Jane True | VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead | Pfizer » speaking at Vaccine Congress USA

Sean Tucker, CSO, Vaxart

Sean Tucker | CSO | Vaxart » speaking at Vaccine Congress USA

Satoshi Uchida, Professor, Tokyo Medical and Dental University (TMDU)

Satoshi Uchida | Professor | Tokyo Medical and Dental University (TMDU) » speaking at Vaccine Congress USA

Arun Upadhyay, Chief Scientific Officer, Ocugen

Robert van den Berg, Founder, Vandenberg D&B

Rob van den Bergh, Regional Director, sub-Saharan Africa, Oximio

Simon van Haren, Assistant Professor of Pediatrics, Harvard Medical School, and PI, Boston Childrens Hospital, Boston Children's Hospital

Andrew Van Kessel, Director of Research, Vaccine and Infectious Disease Organization

Sanjay Vashee, Director of Rockville Campus and Professor, J. Craig Venter Institute

Tonya Villafana, Vice President, Global Franchise Head, AstraZeneca

Rohan Vilms, Medical Director, Parexel

Rohan Vilms | Medical Director | Parexel » speaking at Vaccine Congress USA

Carla Vinals, VP, Global Regulatory Product Strategy, Moderna

Gerard Vondeling, Director Market Acces & Value Evidence, Valneva

Gerard Vondeling | Director Market Acces & Value Evidence | Valneva » speaking at Vaccine Congress USA

Sudhakar Voruganti, Director, Business Development, Pfanstiehl Inc

Adam Waickman, Associate Professor, SUNY Upstate Medical University

Adam Waickman | Associate Professor | SUNY Upstate Medical University » speaking at Vaccine Congress USA

Mia Waldron, Assistant Professor, Nursing, Salisbury University

Saul Walker, Director of Public Partnerships, CEPI

Laura Walker, Head, Infectious Disease Biotherapeutics Discovery & Engineering, Moderna

Laura Walker | Head, Infectious Disease Biotherapeutics Discovery & Engineering | Moderna » speaking at Vaccine Congress USA

Robert Walker, Chief Medical Officer, Novavax

Don Walkinshaw, Senior Director, Consulting, Shift Health

Don Walkinshaw | Senior Director, Consulting | Shift Health » speaking at Vaccine Congress USA

Katrine Wallace, Epidemiologist, University of Illlinois Chicago

Carole Wallis, Medical Director, BARC-SA / CERBA Research

Maggie Haitian Wang, Founder, Beth Bioinformatics Co., Ltd

Reggie Ware, Chief Executive Officer, BlackDoctor.org

Marc Wartenberger, Senior Director Corporate QA and Compliance, Clinical Research IO (CRIO)

Jim Wassil, Chief Operating Officer, Vaxcyte

Jim Wassil | Chief Operating Officer | Vaxcyte » speaking at Vaccine Congress USA

Chih-Jen Wei, Head of Synthetic Biology, ModeX Therapeutics

Chih-Jen Wei | Head of Synthetic Biology | ModeX Therapeutics » speaking at Vaccine Congress USA

David Weiner, Executive Vice President and Director of Vaccine and Immunotherapy Center, The Wistar Institute

Anna-Rose Welch, Editorial and Community Director, Advancing RNA, Life Science Connect

Vanessa Werthenbach, Business Development Manager, Cytiva

Melinda Wharton, Associate Director for Vaccine Policy, CDC

Fenton Whelan, CEO, Acasus

Fenton Whelan | CEO | Acasus » speaking at Vaccine Congress USA

John Wherry, Director, Institute for Immunology & Co-Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania

Chris White, Health Scientist, BARDA, BARDA

Nigel Whittle, Regional Head UK/EU, DRK Pharma Solutions GmbH

Wassana Wijagkanalan, Scientifc Advisor, BioNet

Jamie Wilkins, Head- Risk Management Center of Excellence, Pfizer

Patrick Wilson, Anne E. Dyson Professor of Pediatric Research, Weill Cornell Medical College, Cornell University

Patrick Wilson | Anne E. Dyson Professor of Pediatric Research, Weill Cornell Medical College | Cornell University » speaking at Vaccine Congress USA

Eleanor Wilson, Senior Director, Moderna

Claire Wingfield, Director, Partnerships & Advocacy, FIND

Markus Winterberg, Head of Analytical Development, Microbiology, and Quality Control, LTS Lohmann

Stephanie Wisner, Chief Business Officer, Centivax

Stephanie Wisner | Chief Business Officer | Centivax » speaking at Vaccine Congress USA

Daniel Wolfe, Branch Chief, BARDA CBRN Vaccines, Biomedical Advanced Research And Development Authority

Thad Wolfram, President, EmVenio

Andrew Wong, Business Development Director, Walvax

Gillian Woollett, VP, Head Regulatory Strategy and Policy, Samsung Bioepis

Yelin Xiong, Vice President, Yither Biotech Ltd

Rong Xu, CSO, Delonix Bioworks

Chunping Xu, Senior Director of Chemistry R&D, TriLink BioTechnologies

Prashant Yadav, Affiliate Professor of Technology & Operations Management and Faculty Director, Africa Initiative, INSEAD

Justin Yang, Advisor, Global Health Investment Corporation

In-Kyu Yoon, Acting Executive Director of Research & Development, CEPI

Peter Young, Executive In Residence, Pappas Capital

Peter Young | Executive In Residence | Pappas Capital » speaking at Vaccine Congress USA

Catharine Young, The White House Office of Science and Technology Policy

Jason Zhang, Chief Executive Officer and Co-Founder, Zipcode Bio

Kate Zhang, Chief Scientific Officer, Hopewell Therapeutics

Kate Zhang | Chief Scientific Officer | Hopewell Therapeutics » speaking at Vaccine Congress USA

Chanfeng Zhao, Vice President of R&D Chemistry, TriLink Biotechnologies

Mauricio Zuma Medeiros, Chief Executive Officer, Bio-Manguinhos, Fiocruz

Mauricio Zuma Medeiros | Chief Executive Officer | Bio-Manguinhos, Fiocruz » speaking at Vaccine Congress USA